United Therapeutics and Actavis shake hands over blood pressure drug

16-02-2018

United Therapeutics and Actavis shake hands over blood pressure drug

blackjack3d / iStockphoto.com

Biotechnology company United Therapeutics has reached a settlement with Actavis Laboratories to resolve a dispute over patents concerning a blood pressure drug.


United Therapeutics, Actavis Laboratories, Orenitram, trepostinil, blood pressure drugs, Orphan Drug Act, orphan drug developer, rare disease patent,

LSIPR